期刊文献+

Provision of primary care by specialist physicians:a systematic review 被引量:1

原文传递
导出
摘要 Patients with stable chronic diseases such as diabetes and hypertension can be safely managed at the primary care level.Yet many such patients continue to follow-up with specialists at a higher expense with no added benefit.We introduce a new term to describe this phenomenon:scope inversion,defined as the provision of primary care by specialist physicians.We aimed to quantify the extent of scope inversion by conducting a systematic review.MEDLINE and five other databases were searched using the keywords‘specialist AND(routine OR primary)AND provi*’as well as other variations.The search was limited to human research without restrictions on language or date of publication.The inclusion criterion was studies on rates of the provision of routine primary care by specialist physicians.Thirteen observational studies met the inclusion criteria.A wide range of primary care involvement was observed among specialists,from 2.6%to 65%of clinic visits.Among children,41.3%of visits with specialists were routine follow-ups for conditions such as allergic rhinitis and seborrhoeic dermatitis which could be managed in primary care.Data quality was moderate to low across the studies due to limitations of source data and varying definitions of primary care.Specialist physicians provide primary care to patients in a substantial proportion of clinic visits.Scope inversion is wasteful as it diverts patients to more expensive care without improving outcomes.A systems approach is needed to mitigate scope inversion and its harmful effects on healthcare service delivery.
出处 《Family Medicine and Community Health》 2020年第1期20-23,共4页 家庭医学与社区卫生(英文)
  • 相关文献

参考文献3

二级参考文献43

  • 1Oxman AD,Cook DJ,Guyatt GH.Users' guides to the medical literature.Ⅵ.How to use an overview.Evidence-Based Medicine Working Group.JAMA.1994;272(17):1367-1371.
  • 2Swingler GH,Volmink J,Ioannidis JP.Number of published systematic reviews and global burden of disease:Database analysis.BMJ.2003.327(7423):1083-1084.
  • 3Canadian Institutes of Health Research.Randomized controlled trials registration/application checklist(12/2006)[2009-05-19].http://www.cihr-irsc.gc.ca/e/documents/rct_reg_e.pdf.
  • 4Young C,Horton R.Putting clinical trials into context.Lancet.2005;366(9480):107-108.
  • 5Mulrow CD.The medical review article:state of the science.Ann Intern Med.1987;106(3):485-488.
  • 6Sacks HS,Berrier J,Reitman D,Ancona-Berk VA,Chalmers TC.Meta-analysis of randomized controlled trials.New Engl J Med.1987;316(8):450-455.
  • 7Sacks HS,Reitman D,Pagano D,Kupelnick B.Meta-analysis:an update.Mt Sinai J Med.1996;63(3-4):216-224.
  • 8Moher D,Cook DJ,Eastwood S,Olkin I,Rennie D,Stroup DF.Improving the quality of reporting of meta-analysis of randomized controlled trials:The QUOROM statement.Lancet.1994;354(9193):1896-1900.
  • 9Green S,Higgins J.Glossary.Cochrane handbook for systematic reviews of interventions 4.2.5.The Cochrane Collaboration[2009-05-19].http://www.cochrane.org/resources/glossary.htm.
  • 10Strech D,Tilburt J.Value judgments in the analysis and synthesis of evidence.J Clin Epidemiol.2008;61(6):521-524.

共引文献175

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部